Myriad Genetics and Flatiron Health Collaborate to Expand Access to Genetic Testing Through EMR Integration
QIAGEN and Illumina Unveil New Solutions to Advance Liquid Biopsy and Next-Generation Sequencing
The Role of Biobanks in Advancing Precision Medicine
AstraZeneca and Daiichi Sankyo's Enhertu Secures Conditional Approval in China for HER2-Mutated NSCLC Treatment
SkylineDx Presents Breakthrough Data from Largest Melanoma Genomic Assay Trial at SMR Annual Meeting
Clario and PathAI Join Forces to Streamline GI Clinical Trials with Integrated Solutions
FDA Approves FoundationOne® Liquid CDx as Companion Diagnostic for Itovebi™ (inavolisib) to Identify Hormone Receptor-Positive, HER2-Negative Breast Cancer Patients with PIK3CA Mutation
Roche’s VENTANA CLDN18 (43-14A) RxDx Assay for Identifying Gastric and GEJ Cancer Patients Receives CE Mark Approval
Tempest and Roche Partner to Advance Amezalpat Combination Therapy into First-Line Hepatocellular Carcinoma Pivotal Trial
Singapore to Expand MediShield Life Coverage for Precision Medicine and Strengthen Genetic Data Protections
Bayer and MOMA Therapeutics Partner to Advance Precision Oncology Therapies
DermTech's Non-Invasive Genomic Testing Shows Promise in Differentiating Melanoma from Atypical Moles
Velsera and Diagnostic Longwood Partner to Accelerate Precision Medicine in Spain and Portugal
Aurigene Oncology Reports Promising Phase 1 Results for India’s First CAR-T Cell Therapy in Multiple Myeloma
Agilus Diagnostics Launches Pharmacogenomics Testing Service to Revolutionize Personalized Medicine
